1. Home
  2. NEO vs DCO Comparison

NEO vs DCO Comparison

Compare NEO & DCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • DCO
  • Stock Information
  • Founded
  • NEO 2001
  • DCO 1849
  • Country
  • NEO United States
  • DCO United States
  • Employees
  • NEO N/A
  • DCO N/A
  • Industry
  • NEO Precision Instruments
  • DCO Military/Government/Technical
  • Sector
  • NEO Health Care
  • DCO Industrials
  • Exchange
  • NEO Nasdaq
  • DCO Nasdaq
  • Market Cap
  • NEO 965.2M
  • DCO 1.1B
  • IPO Year
  • NEO 1999
  • DCO N/A
  • Fundamental
  • Price
  • NEO $7.00
  • DCO $80.50
  • Analyst Decision
  • NEO Buy
  • DCO Strong Buy
  • Analyst Count
  • NEO 9
  • DCO 2
  • Target Price
  • NEO $13.31
  • DCO $83.50
  • AVG Volume (30 Days)
  • NEO 2.0M
  • DCO 115.4K
  • Earning Date
  • NEO 07-28-2025
  • DCO 08-07-2025
  • Dividend Yield
  • NEO N/A
  • DCO N/A
  • EPS Growth
  • NEO N/A
  • DCO 93.69
  • EPS
  • NEO N/A
  • DCO 2.33
  • Revenue
  • NEO $672,361,000.00
  • DCO $789,818,000.00
  • Revenue This Year
  • NEO $13.97
  • DCO $5.97
  • Revenue Next Year
  • NEO $11.36
  • DCO $6.59
  • P/E Ratio
  • NEO N/A
  • DCO $34.57
  • Revenue Growth
  • NEO 10.10
  • DCO 3.02
  • 52 Week Low
  • NEO $6.08
  • DCO $51.76
  • 52 Week High
  • NEO $19.12
  • DCO $81.07
  • Technical
  • Relative Strength Index (RSI)
  • NEO 40.74
  • DCO 88.96
  • Support Level
  • NEO $6.90
  • DCO $73.77
  • Resistance Level
  • NEO $7.42
  • DCO $81.07
  • Average True Range (ATR)
  • NEO 0.39
  • DCO 1.50
  • MACD
  • NEO -0.00
  • DCO 0.42
  • Stochastic Oscillator
  • NEO 13.01
  • DCO 95.04

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

Share on Social Networks: